As type and severity of GI disease influence fasting and post-prandial GLP-2 secretion patterns in humans with IBD [22–27], including a range of disease in our population, rather than focusing on dogs with ileal disease, may have limited the ability to observe relationships between microbiota and GLP-2 concentrations. Here, GCG is linked to inflammatory bowel disease.